Parietal Epithelial Cell Behavior and Its Modulation by microRNA-193a.

Area of Science:

• Nephrology
• Cell Biology
• Molecular Medicine

Background:

• Glomerular parietal epithelial cells (PECs) exhibit both reparative and pathogenic functions.
• Activated PECs contribute to glomerular diseases such as focal segmental glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CrescGN).
• The behavior of PECs is modulated by the local microenvironment and specific mediators.

Purpose of the Study:

• To review the critical roles of PECs in glomerular health and disease.
• To explore the influence of microRNA-193a (miR193a) on PEC behavior and kidney pathology.
• To highlight the dual nature of PECs as potentially reparative or pathogenic.

Main Methods:

• Literature review of recent studies on PECs and miR193a.
• Analysis of findings from animal models of FSGS and CrescGN.
• Inclusion of in vitro evidence regarding PEC trans-differentiation.

Main Results:

• PECs can adopt a podocyte phenotype during glomerular development and injury, suggesting a reparative capacity.
• Aberrant PEC activation contributes to extracapillary proliferation in FSGS and CrescGN.
• miR193a is implicated in FSGS pathogenesis by downregulating Wilms' tumor protein and causing podocyte dedifferentiation.
• Inhibition of miR193a ameliorates crescent formation in CrescGN models.
• Downregulation of miR193a promotes PEC trans-differentiation into podocytes in vitro.

Conclusions:

• PECs possess a dynamic behavior that can be either beneficial or detrimental to kidney function.
• miR193a acts as a key regulator of PEC phenotype and function.
• Targeting miR193a may offer therapeutic strategies for glomerular diseases characterized by PEC dysfunction.